共 50 条
- [1] Carfilzomib, lenalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience [J]. TERAPEVTICHESKII ARKHIV, 2021, 93 (07): : 785 - 792
- [3] Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study [J]. MEDICINA-LITHUANIA, 2021, 57 (09):